{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:15:18Z","timestamp":1783725318439,"version":"3.55.0"},"reference-count":41,"publisher":"Georg Thieme Verlag KG","funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"crossref","award":["BB\/T017686\/1"],"award-info":[{"award-number":["BB\/T017686\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["FS\/19\/69\/34639 ,FS\/PhD\/23\/29394"],"award-info":[{"award-number":["FS\/19\/69\/34639 ,FS\/PhD\/23\/29394"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"abstract":"<jats:p>Type 1 diabetes (T1D) is associated with prothrombotic changes that contribute to an elevated risk of cardiovascular disease. We hypothesised that insulin resistance (IR), increasingly prevalent among individuals with T1D, exacerbates haemostatic abnormalities through distinct proteomic alterations in plasma. In a cross-sectional observational study, citrated plasma was collected from individuals with T1D (with and without IR) and healthy controls. Fibrin clot formation and lysis were assessed using turbidimetric assays. Plasma proteomes were analysed using data-independent acquisition mass spectrometry (DIA-MS), and correlations between protein abundance and clinical parameters were evaluated. T1D plasma exhibited faster clot initiation, increased clot density, and impaired fibrinolysis. Effects on clot lysis were most pronounced in individuals with IR. DIA-MS revealed distinct proteomic signatures, with significant changes in proteins involved in regulating clot structure and breakdown. Notably, clot density correlated positively with fibrinogen gamma-chain abundance. T1D is characterised by prothrombotic alterations that are further intensified by IR. Our findings reveal that these changes are driven by proteomic shifts affecting clot initiation, structural integrity, fibrinolysis, and inflammatory pathways, offering mechanistic insights and potential targets for mitigating cardiovascular risk in this population.<\/jats:p>","DOI":"10.1055\/a-2873-8027","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:50:31Z","timestamp":1783723831000},"source":"Crossref","is-referenced-by-count":0,"title":["Quantitative Proteomic Profiling of Plasma Alterations Associated with Thrombotic Risk and Insulin Resistance in Type 1 Diabetes"],"prefix":"10.1055","author":[{"given":"Claudia A. A.","family":"Harper","sequence":"first","affiliation":[{"name":"University of St Andrews, Scotland, United Kingdom","place":["St Andrews"],"department":["School of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan S.","family":"Marsh","sequence":"first","affiliation":[{"name":"University of St Andrews, Scotland, United Kingdom","place":["St Andrews"],"department":["School of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco F.","family":"Fernandes","sequence":"first","affiliation":[{"name":"University of St Andrews, Scotland, United Kingdom","place":["St Andrews"],"department":["School of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Sagar","sequence":"first","affiliation":[{"name":"University of Leeds, England, United Kingdom","place":["Leeds"],"department":["Leeds Institute of Cardiovascular and Metabolic Medicine"]},{"name":"Leeds Teaching Hospitals Trust, United Kingdom","place":["Leeds"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia A.","family":"Synowsky","sequence":"additional","affiliation":[{"name":"University of St Andrews, Biomedical Sciences Research Complex, United Kingdom","place":["St Andrews"],"department":["Schools of Chemistry and Biology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasnain","family":"Ahmed","sequence":"additional","affiliation":[{"name":"University of St Andrews, Scotland, United Kingdom","place":["St Andrews"],"department":["School of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally L.","family":"Shirran","sequence":"additional","affiliation":[{"name":"University of St Andrews, Biomedical Sciences Research Complex, United Kingdom","place":["St Andrews"],"department":["Schools of Chemistry and Biology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid M.","family":"Naseem","sequence":"additional","affiliation":[{"name":"University of Leeds, England, United Kingdom","place":["Leeds"],"department":["Leeds Institute of Cardiovascular and Metabolic Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi A.","family":"Ajjan","sequence":"additional","affiliation":[{"name":"University of Leeds, England, United Kingdom","place":["Leeds"],"department":["Leeds Institute of Cardiovascular and Metabolic Medicine"]},{"name":"Leeds Teaching Hospitals Trust, United Kingdom","place":["Leeds"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4580-1840","authenticated-orcid":false,"given":"Alan J.","family":"Stewart","sequence":"additional","affiliation":[{"name":"University of St Andrews, Scotland, United Kingdom","place":["St Andrews"],"department":["School of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"A Katsarou","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","article-title":"Cardiovascular risk in type 1 diabetes mellitus","volume":"10","author":"J Schofield","year":"2019","journal-title":"Diabetes Ther"},{"issue":"08","key":"ref3","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3390\/jcm10081798","article-title":"Cardiovascular disease in type 1 diabetes mellitus: Epidemiology and management of cardiovascular risk","volume":"10","author":"C Colom","year":"2021","journal-title":"J Clin Med"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1111\/dom.13848","article-title":"Double diabetes: a distinct high-risk group?","volume":"21","author":"N Kietsiriroje","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12933-024-02145-x","article-title":"Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition","volume":"23","author":"W Bielka","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"03","key":"ref6","first-page":"e80495","article-title":"Double diabetes: a converging metabolic and autoimmune disorder redefining the classification and management of diabetes","volume":"17","author":"R K Chaudhary","year":"2025","journal-title":"Cureus"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5152\/eurasianjmed.2022.21039","article-title":"Prevalence of insulin resistance in type 1 diabetes mellitus and its correlation with metabolic parameters: the double trouble","volume":"54","author":"V Pathak","year":"2022","journal-title":"Eurasian J Med"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/dc24-0475","article-title":"Association of insulin resistance with cardiovascular disease and all-cause mortality in type 1 diabetes: systematic review and meta-analyses","volume":"47","author":"R Sun","year":"2024","journal-title":"Diabetes Care"},{"issue":"07","key":"ref9","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1007\/s00125-013-2904-2","article-title":"Insulin resistance in type 1 diabetes: what is \u2018double diabetes\u2019 and what are the risks?","volume":"56","author":"S J Cleland","year":"2013","journal-title":"Diabetologia"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41387-019-0101-1","article-title":"Double or hybrid diabetes: a systematic review on disease prevalence, characteristics and risk factors","volume":"9","author":"J Khawandanah","year":"2019","journal-title":"Nutr Diabetes"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2796.2007.01824.x","article-title":"Diabetes mellitus as a prothrombotic condition","volume":"262","author":"P J Grant","year":"2007","journal-title":"J Intern Med"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/VHRM.S4248","article-title":"Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization","volume":"5","author":"C Cola","year":"2009","journal-title":"Vasc Health Risk Manag"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12933-017-0515-9","article-title":"Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk","volume":"16","author":"K Kearney","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-0039-3402808","article-title":"Reduced plasma magnesium levels associate with prothrombotic changes in fibrin clotting and fibrinolysis in type-1 diabetes","volume":"120","author":"A IS Sobczak","year":"2020","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1039\/D0SC06605B","article-title":"Albumin-mediated alteration of plasma zinc speciation by fatty acids modulates blood clotting in type-2 diabetes","volume":"12","author":"A IS Sobczak","year":"2021","journal-title":"Chem Sci (Camb)"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12933-021-01230-9","article-title":"Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long-term follow-up study","volume":"20","author":"A H Bryk","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12933-022-01498-5","article-title":"Nine-fold higher risk of acute myocardial infarction in subjects with type 1 diabetes compared to controls in Norway 1973-2017","volume":"21","author":"M Saeed","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"07","key":"ref18","doi-asserted-by":"crossref","first-page":"e213480","DOI":"10.1212\/WNL.0000000000213480","article-title":"Risk of ischemic and hemorrhagic stroke in individuals with type 1 and type 2 diabetes: a nationwide cohort study in Sweden","volume":"104","author":"A Mavridis","year":"2025","journal-title":"Neurology"},{"issue":"10","key":"ref19","first-page":"e47993","article-title":"Prevalence and risk factors of retinopathy in type 1 diabetes: a cross-sectional study","volume":"15","author":"S Berrabeh","year":"2023","journal-title":"Cureus"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2337\/dc18-2062","article-title":"Risk factors for kidney disease in type 1 diabetes","volume":"42","author":"B A Perkins","year":"2019","journal-title":"Diabetes Care"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/dc19-1582","article-title":"SDRNT1BIO Investigators. Diabetic neuropathy is a substantial burden in people with type 1 diabetes and is strongly associated with socioeconomic disadvantage: a population-representative study from Scotland","volume":"43","author":"A Jeyam","year":"2020","journal-title":"Diabetes Care"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12933-025-02672-1","article-title":"Insulin resistance quantified by estimated glucose disposal rate predicts cardiovascular disease incidence: a nationwide prospective cohort study","volume":"24","author":"S Tao","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","article-title":"Can clinical factors estimate insulin resistance in type 1 diabetes?","volume":"49","author":"K V Williams","year":"2000","journal-title":"Diabetes"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood-2007-05-091231","article-title":"Common variation in the C-terminal region of the fibrinogen \u03b2-chain: effects on fibrin structure, fibrinolysis and clot rigidity","volume":"111","author":"R Ajjan","year":"2008","journal-title":"Blood"},{"issue":"05","key":"ref25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ijlh.12688","article-title":"Global assays of fibrinolysis","volume":"39","author":"A Ilich","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"09","key":"ref26","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1021\/acs.jproteome.2c00145","article-title":"Protein contaminants matter: building universal protein contaminant libraries for DDA and DIA proteomics","volume":"21","author":"A M Frankenfield","year":"2022","journal-title":"J Proteome Res"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2141.2004.05009.x","article-title":"Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease","volume":"126","author":"P M Mannucci","year":"2004","journal-title":"Br J Haematol"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.thromres.2011.08.001","article-title":"The endothelial cell protein C receptor: its role in thrombosis","volume":"128","author":"S Navarro","year":"2011","journal-title":"Thromb Res"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.diabres.2014.09.007","article-title":"Soluble endothelial protein C receptor and high sensitivity C reactive protein levels as markers of endothelial dysfunction in patients with type 1 and type 2 diabetes mellitus: their role in the prediction of vascular complications","volume":"106","author":"A Zaghloul","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"09","key":"ref30","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1987.03400090067035","article-title":"Fibrinogen and risk of cardiovascular disease. The Framingham study","volume":"258","author":"W B Kannel","year":"1987","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1749-6632.2001.tb03544.x","article-title":"Fibrinogen and its degradation products as thrombotic risk factors","volume":"936","author":"G D Lowe","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"14","key":"ref32","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"J Danesh","year":"2005","journal-title":"JAMA"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/j.1538-7836.2003.0543b.x","article-title":"High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly","volume":"1","author":"A van Hylckama Vlieg","year":"2003","journal-title":"J Thromb Haemost"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1721727X1100900202","article-title":"Inflammatory markers: Serum amyloid A, fibrinogen and C-reactive protein \u2013 a revisited study","volume":"9","author":"V Salini","year":"2011","journal-title":"Eur J Inflamm"},{"issue":"23","key":"ref35","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2009-11-256610","article-title":"Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain","volume":"115","author":"H M Andersson","year":"2010","journal-title":"Blood"},{"issue":"04","key":"ref36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jth.13261","article-title":"Structure-function relationships in thrombin-activatable fibrinolysis inhibitor","volume":"14","author":"T Plug","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.thromres.2009.11.028","article-title":"Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis","volume":"125","author":"E Stavrou","year":"2010","journal-title":"Thromb Res"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/biomedicines13051207","article-title":"New insights in the diagnostic potential of sex hormone-binding globulin (SHBG)\u2014clinical approach","volume":"13","author":"W Szybiak-Skora","year":"2025","journal-title":"Biomedicines"},{"issue":"S 01","key":"ref39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1538-7836.2007.02516.x","article-title":"Serpins in thrombosis, hemostasis and fibrinolysis","volume":"5","author":"J C Rau","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"T V Rohm","year":"2022","journal-title":"Immunity"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"883743","DOI":"10.3389\/fimmu.2022.883743","article-title":"The hidden side of complement regulator C4BP: dissection and evaluation of its immunomodulatory activity","volume":"13","author":"I Serrano","year":"2022","journal-title":"Front Immunol"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2873-8027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:50:36Z","timestamp":1783723836000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2873-8027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1055\/a-2873-8027","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}